ML-179 (Synonyms: CID45100448) |
Catalog No.GC44215 |
ML-179 (SR-1309) es un agonista inverso de LRH1 (homólogo del receptor hepático 1) con IC50 de 320 nM. ML-179 muestra actividad antiproliferación en células MDA-MB-231. ML-179 tiene el potencial para la investigación del cáncer de mama ER-negativo.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1883548-87-5
Sample solution is provided at 25 µL, 10mM.
ML-179 is a potent inverse agonist of liver receptor homolog-1 (LRH-1) (IC50 = 320 nM) with maximum efficacy of 40% repression. It is inactive at the related steroidogenic factor-1 transcriptional activator. Through LRH-1, ML-180 alters the expression of haptoglobin and serum amyloid proteins A1 and A4, induces the death of estrogen-receptor negative MDA-MB-231 breast cancer cells, and inhibits the steroidogenic acute regulatory promoter (IC50 = 2.12 µM).
Average Rating: 5
(Based on Reviews and 7 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *